Retina/Vitreous - Eye Health Academy

1-16 of 33

Faricimab vs. Aflibercept for Retinal Vein Occlusion
Faricimab vs. Aflibercept for Retinal Vein Occlusion
Eye on Ocular Health
Faricimab vs. Aflibercept for Retinal Vein Occlusion
Michael Javaheri, MD, MSc, FASRS
- Michael Javaheri, MD, MSc, FASRS
Choosing the Right Therapy for RVO Patients
Choosing the Right Therapy for RVO Patients
Eye on Ocular Health
Choosing the Right Therapy for RVO Patients
Michael Javaheri, MD, MSc, FASRS
- Michael Javaheri, MD, MSc, FASRS
Managing RVO: Goals of Early Intervention
Managing RVO: Goals of Early Intervention
Eye on Ocular Health
Managing RVO: Goals of Early Intervention
Michael Javaheri, MD, MSc, FASRS
- Michael Javaheri, MD, MSc, FASRS
Highlights from VBS 2026: From Care Innovations to Clinician Wellness
Highlights from VBS 2026: From Care Innovations to Clinician Wellness
Eye on Ocular Health
Highlights from VBS 2026: From Care Innovations to Clinician Wellness
Akshay Thomas, M.D., M.S., FASRS
- Akshay Thomas, M.D., M.S., FASRS
Balancing Urgency and Outcomes in Macula-Off Retinal Detachment Surgery
Balancing Urgency and Outcomes in Macula-Off Retinal Detachment Surgery
Eye on Ocular Health
Balancing Urgency and Outcomes in Macula-Off Retinal Detachment Surgery
Akshay Thomas, M.D., M.S., FASRS
- Akshay Thomas, M.D., M.S., FASRS
Ischemic vs. Non-Ischemic RVO: How Do You Know?
Ischemic vs. Non-Ischemic RVO: How Do You Know?
Eye on Ocular Health
Ischemic vs. Non-Ischemic RVO: How Do You Know?
Jessica Randolph, MD
- Jessica Randolph, MD
Retinal Vein Occlusion in Younger Patients: Key Care Considerations
Retinal Vein Occlusion in Younger Patients: Key Care Considerations
Eye on Ocular Health
Retinal Vein Occlusion in Younger Patients: Key Care Considerations
Jessica Randolph, MD
- Jessica Randolph, MD
Retinal Vein Occlusion as a Marker of Systemic Risk
Retinal Vein Occlusion as a Marker of Systemic Risk
Eye on Ocular Health
Retinal Vein Occlusion as a Marker of Systemic Risk
Ashkan Abbey, MD
- Ashkan Abbey, MD
Logistical Considerations with Anti-VEGF Treatment in Wet AMD
Logistical Considerations with Anti-VEGF Treatment in Wet AMD
Eye on Ocular Health
Logistical Considerations with Anti-VEGF Treatment in Wet AMD
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
Eye on Ocular Health
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
Ashkan Abbey, MD
- Ashkan Abbey, MD
Identifying Central and Branch Retinal Vein Occlusion
Identifying Central and Branch Retinal Vein Occlusion
Eye on Ocular Health
Identifying Central and Branch Retinal Vein Occlusion
Jessica Randolph, MD
- Jessica Randolph, MD
Retinal Vein Occlusion: The Case for Prompt Treatment
Retinal Vein Occlusion: The Case for Prompt Treatment
Eye on Ocular Health
Retinal Vein Occlusion: The Case for Prompt Treatment
Ashkan Abbey, MD
- Ashkan Abbey, MD
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Eye on Ocular Health
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Ryan Quigley
- Ryan Quigley
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Chin Yee, MD, FASRS
0.25 credits
- David Chin Yee, MD, FASRS
0.25 credits
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Eichenbaum, MD
0.25 credits
- David Eichenbaum, MD
0.25 credits
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Deepak Sambhara, MD
0.25 credits
- Deepak Sambhara, MD
0.25 credits

Prev
1
2
3
Next

1/3